Hege G. Russnes

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

Assessing clinical decision support system tools in precision oncology: piloting ring testing.

Assessing clinical decision support system tools in precision oncology: piloting ring testing.

Journal: ESMO real world data and digital oncology

Published: July 28, 2026

Correction: Lien et al. Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer. Cancers 2021, 13, 6118.

Correction: Lien et al. Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer. Cancers 2021, 13, 6118.

Journal: Cancers

Published: March 25, 2026

Towards an ecosystem of clinical decision support tools for precision cancer medicine.

Towards an ecosystem of clinical decision support tools for precision cancer medicine.

Journal: NPJ precision oncology

Published: December 30, 2025

Merging clinical research and standard healthcare - Nordic Precision Cancer Medicine Symposium 2025.

Merging clinical research and standard healthcare - Nordic Precision Cancer Medicine Symposium 2025.

Journal: Acta oncologica (Stockholm, Sweden)

Published: December 10, 2025

A comprehensive assessment of the existing landscape of personalized cancer medicine in the European Union, on behalf of the PCM4EU consortium.

A comprehensive assessment of the existing landscape of personalized cancer medicine in the European Union, on behalf of the PCM4EU consortium.

Journal: ESMO open

Published: July 29, 2025

Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives.

Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives.

Journal: Clinical breast cancer

Published: March 17, 2025

Microcosting Study of Genomic Profiling for Precision Cancer Medicine: Application from the National Infrastructure for Precision Diagnostics in Norway.

Microcosting Study of Genomic Profiling for Precision Cancer Medicine: Application from the National Infrastructure for Precision Diagnostics in Norway.

Journal: The Journal of molecular diagnostics : JMD

Published: March 05, 2025

High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis.

High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis.

Journal: Communications medicine

Published: October 20, 2024

Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient.

Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient.

Journal: Cell death & disease

Published: September 02, 2024

Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes.

Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes.

Journal: BJC reports

Published: July 08, 2024

High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyond.

High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyond.

Journal: Journal of internal medicine

Published: May 03, 2024

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials.

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials.

Journal: Molecular oncology

Published: February 14, 2024

Showing 1-12 of 81

Last Updated: 09/26/2026